Will Genscript Cash Out Of Legend Biotech In The Face Of Fat Profit Temptation? Key Takeaways: Analysts expect annual sales of Carvykti, Legend Biotech’s core cancer therapy, to peak at $7.3 billion ...

PISCATAWAY, N.J., March 26, 2025 /PRNewswire/ -- GenScript Biotech Corporation (GenScript), a global leader in life sciences research, manufacturing technologies and production services, has been ...

Recent price moves and business snapshot Genscript Biotech (SEHK:1548) has seen the stock slip about 0.5% on the day and roughly 5.6% over the past week, while posting a gain of around 13% over the ...

The share-price surge came as promising cancer trial data overshadowed continuing scrutiny of China's biotechnology sector by US lawmakers GenScript Biotech Holdings surged in Hong Kong after its ...

In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...

GENSCRIPT BIOTECH (01548.HK) announced that its subsidiary Legend Biotech, pursuant to its collaboration and license ...

(Reuters) -The U.S. House of Representatives committee on China on Tuesday sent a letter to the directors of the FBI and national intelligence, renewing its concerns about GenScript Biotechnology's ...

Join us as we delve into the forefront of SARS-CoV-2 diagnostics and GenScript's transformative impact in the fight against COVID-19. We'll discuss the emergence of COVID-19 and GenScript's rapid ...

The two biotech leaders have embarked on a research project to streamline manufacturing The two biotech leaders have embarked on a research project to streamline manufacturing GenScript – the ...

No-moat GenScript’s 01548 full-year results were in line with our expectations. Companywide revenue for the year was within 2% of our expectations. However, revenue growth from the non-cell therapy ...

In the past decade, gene editing has been increasingly emphasized as an essential tool for therapy development. This has led to significant scientific advances in understanding disease mechanisms and ...

Shares of Genscript Biotech jumped 20 per cent after the company said the government had accepted its application for running clinical trials for its blood cancer treatment. The company, one of the ...